Trader Note — 9349 total
Aclaris Therapeutics reports Q1 results tomorrow morning with a setup that cuts several ways at once: a fresh analyst initiation, a put/call ratio at its highest level in a year, and short sellers holding a meaningful…
KURA reports on June 4 with short sellers at their most aggressive in months and the stock down 14% on the week — the question now is whether Komzifti's commercial numbers can shift that conviction. Short interest has…
Houlihan Lokey enters June with a straightforward but uncomfortable setup: a cluster of C-suite sales at the exact top of the recent range, a stock that has since dropped 8.9% over the past month to $139.43, and short…
KHC enters the first week of June with two converging pressures: a fresh analyst downgrade from Bernstein and short interest that has climbed to its highest level in the 30-day window tracked here. The most striking…
Spyre Therapeutics enters June with an unusual combination: a stock that has drifted 6% lower on the week while the Street is broadly bullish, insider selling has been persistent, and short positions have quietly…
OLLI has reported June 3 earnings, and the week's central tension is now clear: short sellers are holding firm at elevated levels while the stock trades at a steep discount to where analysts think it belongs. The short…
ABVX entered June with what should have been its finest hour. The Phase 3 ABTECT maintenance trial for obefazimod in ulcerative colitis met its primary endpoint. Instead, shares closed at €63.10 on June 2 — down 43.6%…
FirstService Corporation arrives at a compelling inflection point this week — a freshly expanded share buyback programme collides with the steepest short-interest build in months, even as the stock logs its best weekly…
Shopify heads into its June 16 earnings with a familiar tension: the stock bounced hard this week, and the CEO sold into it again. The insider story continues to be the clearest signal on this name. Tobias Lütke sold…
MDT closed its fiscal fourth quarter with analysts cutting targets on earnings day itself — a clear signal that the Q4 print failed to close the gap between Street expectations and what the company actually…
SHAK enters its June 10 earnings call with the Street in damage-control mode — targets coming down hard, short sellers quietly reducing exposure, and the CEO who bought shares at $62 now watching them slip to $57. The…
Keysight Technologies enters the first week of June having given back some of the post-earnings momentum, with the stock slipping 2.6% on the week to $346.57 — even after a sharp 5% single-day rebound on June 2 that…
VVX enters June as one of the defence sector's quiet outperformers — up 23% over the past month and 10% on the week alone — while most peers retreated, and the Street is still scrambling to reprice it. The most telling…
HealthEquity cleared its June 2 earnings hurdle with a modest gain, but the post-print session has brought sellers back into the stock — and the options market, which was screaming bullish just days ago, has quietly…
Relmada Therapeutics enters June on the back foot, down 16% in a month after a sharp re-rating higher — and fresh dilution news is the clearest explanation for why the momentum has stalled. The most consequential…
DocuSign heads into its June 4 Q1 print with a clear split: options traders are positioned for a rally, short sellers have spent the past month quietly adding to their bets against it. The short interest story has…
ATHM finds itself in an interesting contradiction this week: the stock jumped 11% while its most prominent analyst moved to the sidelines. JP Morgan's Alex Yao lowered his price target on Tuesday — the day of the data…
American Airlines Group heads into its June 10 earnings call with a contradictory setup: the Street is lifting targets, shorts are quietly unwinding, yet the stock fell 6.2% on the week to $13.93 — trading well below…
Allegion enters the week wearing a fresh analyst cut and a stock that has drifted 4% lower over the past month — a combination that keeps the building-products name firmly in the "wait and see" column ahead of its next…
Intercontinental Exchange heads into early June with a familiar tension: the stock has shed another leg lower, short sellers are adding pressure, and the Street's price targets remain far above where the market is…
